Cardiovascular Systems, Inc. provided earnings guidance for the year ending June 30, 2023. For the year, the company expects revenue o of $255 million to $265 million and net loss in a range of 9% to 11% of revenues.
Cardiovascular Systems, Inc.
Equities
CSII
US1416191062
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-4.82% | 182B | |
+1.38% | 111B | |
-2.82% | 68.48B | |
+0.69% | 49.69B | |
+8.54% | 44.46B | |
+2.33% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+15.30% | 25.32B |